Suspicious cells build up in mice that haven’t given birth, a new study finds. They could help explain a longstanding mystery ...

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United ...

Major WHO study analyzing 30 years of research finally settles whether cell phones cause cancer - the results may surprise you.

Zelluna (OSE: ZLNA), a company pioneering allogeneic 'off-the-shelf' T Cell Receptor-based Natural Killer (TCR-NK) cell ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Heaven’s Beverley Mitchell reflected on a life-changing experience when doctors found the “biggest precancerous polyp” on her ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

A cancer dietitian has shared 10 simple diet and lifestyle changes you can make to reduce your risk of cancer, from eating ...

A cancer dietician has shared the 10 steps you can take to try and reduce your risk of cancer, and you can start implementing ...

Injecting viral peptides systemically into mice activated immune cells that then targeted pancreatic tumors, opening avenues to more accessible cancer therapy.

Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, toda ...